최신 재무제표(Form-10K)에 따르면, Artivion Inc의 총 자산은 $0이며, 순손실입니다.
AORT의 주요 재무 비율은 무엇인가요?
Artivion Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Artivion Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Artivion Inc 주요 수익원은 Medical Devices이며, 최신 수익 발표에서 수익은 345,825,000입니다. 지역별로는 United States이 Artivion Inc의 주요 시장이며, 수익은 214,075,000입니다.
Artivion Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Artivion Inc의 순손실은 $0입니다.
Artivion Inc에 부채가 있나요?
no, Artivion Inc의 부채는 0입니다.
Artivion Inc의 발행 주식은 몇 주인가요?
Artivion Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$28.32
시가
$28.8
일일 범위
$28.65 - $29.97
52주 범위
$19.16 - $48.25
거래량
685.6K
평균 거래량
716.9K
배당수익률
--
EPS(TTM)
0.24
시가총액
$1.3B
AORT란 무엇인가요?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. The company has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.